Elisa Alvarez Artero

Mrs. Elisa Alvarez Artero


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
PGPablo González García
Pablo González García
JFJulia Fernández-Navarro
Julia Fernández-Navarro
MBMónica Bru-Arca
Mónica Bru-Arca
EAElisa Alvarez Artero
Elisa Alvarez Artero
PSPablo Solís Sánchez
Pablo Solís Sánchez
JLJavier Pardo Lledias
Javier Pardo Lledias
Objectives: Chronic pulmonary aspergillosis (CPA) is a fungal lung infection characterised by the slowly progressing destruction of the lung parenchyma and has four main subtypes. The objective of this work was to evaluate the epidemiology of CPA in our area and evaluate the involvement of the different subtypes in mortality. Methods: This was a descriptive longitudinal retrospective study developed in three tertiary hospitals in Spain. Among all patients admitted with a pulmonary aspergillosis diagnosis, we selected those who fulfilled the criteria for chronic aspergillosis according to the criteria of Denning, excluding those with a haematological disorder. Results: Among 409 inpatients recorded as having a pulmonary aspergillosis infection, only 76 (18.5%) fulfilled the criteria for CPA, with an estimated incidence of 0.67 cases/100,000 inhabitants/year. The subtypes detected were subacute invasive aspergillosis (SAIA) in 33 (43.4%) patients, simple aspergilloma (SA) in 25 (32.9%) patients, cavitary chronic aspergillosis (CCPA) in 13 (17.1%) patients, and chronic fibrosis (CFPA) in five (6.5%) patients. The overall three-month mortality rate was 23%, which was higher in SAIA patients. The predictors of early mortality were age > 65 years (OR 3.0 CI 95 1.0–9.5 p = 0.043) and the SAIA subtype vs. other subtypes (OR 3.1 CI 95 1.0–9.5 p = 0.042). Conclusions: The incidence rate estimated was inferior to that previously reported. The three-month mortality in patients with CPA was high, with older age and the SAIA subtype being the variable independent predictors of a worse prognosis.

23 October 2024 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
MVMaría Rincón Villar
María Rincón Villar
Montserrat Alonso-SardónMontserrat Alonso-Sardón
Montserrat Alonso-Sardón
EAElisa Alvarez Artero
Elisa Alvarez Artero
BRBeatriz Rodríguez-Alonso
Beatriz Rodríguez-Alonso
ABAmparo Lopez Bernus
Amparo Lopez Bernus
MBMoncef Belhassen-Garcia
Moncef Belhassen-Garcia
In the last 40 years, a significant increase in the incidence of lung infections by Aspergillus has been reported. The scarcity of studies that describe the costs of aspergillosis indicates that the economic impact of aspergillosis in the hospital environment is greater than that of other fungal infections. The objective of the study was to evaluate the direct healthcare costs associated with aspergillosis in the Spanish National Health System from 1997 to 2021. A retrospective nationwide longitudinal descriptive study was designed to review hospital records from the Minimum Basic Data Set of patients admitted to hospitals of the National Health System from 1997 to 2021, with a diagnosis of aspergillosis. A total of 44,586 patients were admitted for aspergillosis in the Spanish National Health System. There was a progressive increase in the average annual cost from 1997 to 2012, which reached a maximum peak, EUR 1,395,154.21 (±2,155,192.87). It decreased between 2014 and 2019, but increased again in 2020 and 2021, EUR 28,675.79 (±30,384.12). The Pearson correlation coefficient revealed a weak negative correlation between age and hospital costs and a moderate positive correlation between average length of stay and hospital costs. Our data show that the economic impact of hospitalizations for aspergillosis is significant and increasing at a rate proportionally higher than that of other prevalent diseases. Costs related to Aspergillus infection are associated mainly with respiratory diseases. The results of this economic evaluation may be useful for health authorities to develop a future economic strategy for managing this fungal infection.

1 May 2017 in Gastroenterología y Hepatología
Verified
Journal Article
Closed access
EAElisa Alvarez Artero
Elisa Alvarez Artero
ANAmaia Campo Núñez
Amaia Campo Núñez
BSBeatriz Albarrán Severo
Beatriz Albarrán Severo
JPJavier Pardo-Lledias
Javier Pardo-Lledias

10 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
PGPablo Gonzalez-Garcia
Pablo Gonzalez-Garcia
JFJulia Fernández-Navarro
Julia Fernández-Navarro
MBMonica Bru-Arca
Monica Bru-Arca
EAElisa Alvarez Artero
Elisa Alvarez Artero
PSPablo Solis Sánchez
Pablo Solis Sánchez
JLJavier Pardo Lledias
Javier Pardo Lledias
Objectives: Chronic pulmonary aspergillosis (CPA) is a fungal lung infection characterized by slowly progressive destruction of the lung parenchyma and has four main subtypes. The objective of this work was to evaluate the epidemiology of CPA in our area and evaluate the involvement of the different subtypes in mortality. Methods: This was a descriptive longitudinal retrospective study developed in three tertiary hospitals in Spain. Among all patients admitted with a pulmonary aspergillosis diagnosis, we selected those who fulfilled the criteria for chronic aspergillosis according to the criteria of Denning, excluding those with a haematological disorder. Results: Among 409 inpatients recorded as having pulmonary aspergillosis infection, only 76 (18.5%) fulfilled the criteria for CPA, with an estimated incidence of 0.67 cases/100,000 inhabitants/year. The subtypes detected were subacute invasive aspergillosis (SAIA) in 33 (43.4%) patients, simple aspergilloma (SA) in 25 (32.9%) patients, cavitary chronic aspergillosis (CCPA) in 13 (17.1%) patients and chronic fibrosant (CFAP) in 5 (6.5%) patients. The overall three-month mortality was 23%, which was higher in SAIA patients. The predictors of early mortality were age >65 years (OR 3.0 CI 95 1.0–9.5 0.043) and SAIA subtype vs. other subtypes (OR 3.1 CI 95 1.0–9.5 p 0.042). Conclusions: The incidence rate estimated was inferior to that previously reported. Three-month mortality in patients with CPA was high, with older age and SAIA subtype being the variable independent predictors of a worse prognosis.